Infectious Diseases Trial of a Long-Acting Malaria Drug Injection Launches in RwandaGlobal Biodefense StaffNovember 5, 2026
CBRNE Radiation Countermeasure Entolimod Clears Mouse Safety Study, Moves to Survival TestGlobal Biodefense StaffNovember 3, 2026
Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response Medical Countermeasures May 22, 2020 …
Large Observational Study Shows No Benefit for Hydroxychloroquine in COVID-19 Patients Medical Countermeasures May 22, 2020 …
Macaques Show Protective Immunity Against SARS-Cov-2 After Infection or Vaccine Medical Countermeasures May 20, 2020 …
COVID-19 Cytokine Storm: Possible Mechanism for the Deadly Respiratory Syndrome Medical Countermeasures May 20, 2020 …
The Challenges of Developing a Safe and Effective COVID-19 Vaccine Medical Countermeasures May 12, 2020 …
NAU Launches Testing Service Center to Evaluate COVID-19 Drug Candidates Medical Countermeasures May 9, 2020 …
NIAID to Hold Closed Meeting on Biodefense Medical Countermeasure Funding Contracts + Grants May 7, 2020 …
Inactivated Vaccine Candidate Protects Macaques From SARS-Cov-2 Infection Medical Countermeasures May 6, 2020 …
NYU Langone Health Enrolling Patients in US Clinical Trial For COVID-19 mRNA Vaccine Medical Countermeasures May 5, 2020 …
Hydroxychloroquine Linked to Increased Risk of Cardiac Arrhythmia Medical Countermeasures May 1, 2020 …
Pharmacists Warn Against Malarial Drugs as a Cure for Coronavirus Medical Countermeasures April 30, 2020 …
NUS-Led Team Develops Artificial Intelligence Platform to Combat Infectious Diseases Medical Countermeasures April 27, 2020 …
Emergex and GMU’s National Center for Biodefense and Infectious Diseases Partner for Highly Pathogenic RNA Virus Studies Industry News April 22, 2020 …
Researchers Develop New Microneedle Array Combination Vaccine Delivery System Medical Countermeasures April 21, 2020 …
Convalescent Plasma Therapy: Johns Hopkins Releases Guidebook, Penn Medicine and UChicago Start Trials Medical Countermeasures April 20, 2020 …
Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients Medical Countermeasures April 20, 2020 …
Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients Medical Countermeasures April 20, 2020 …